4 results on '"Peter M, Boersma"'
Search Results
2. Receipt of First and Second Doses of JYNNEOS Vaccine for Prevention of Monkeypox — United States, May 22–October 10, 2022
- Author
-
Jennifer L, Kriss, Peter M, Boersma, Emalee, Martin, Kirsten, Reed, Jennifer, Adjemian, Nathaniel, Smith, Rosalind J, Carter, Kathrine R, Tan, Arunkumar, Srinivasan, Sunanda, McGarvey, Jennifer, McGehee, Danielle, Henderson, Noah, Aleshire, and Adi V, Gundlapalli
- Subjects
Adult ,Vaccines ,Health (social science) ,Adolescent ,Epidemiology ,Health, Toxicology and Mutagenesis ,Vaccination ,Monkeypox ,General Medicine ,United States ,Health Information Management ,Vaccinia ,Humans ,Smallpox Vaccine ,Aged - Abstract
Vaccination with JYNNEOS vaccine (Modified Vaccinia Ankara vaccine, Bavarian Nordic) to prevent monkeypox commenced shortly after confirmation of the first monkeypox case in the current outbreak in the United States on May 17, 2022 (1). To date, more than 27,000 cases have been reported across all 50 states, the District of Columbia (DC), and Puerto Rico.* JYNNEOS vaccine is licensed by the Food and Drug Administration (FDA) as a 0.5-mL 2-dose series administered subcutaneously 28 days apart to prevent smallpox and monkeypox infections (2) and has been found to provide protection against monkeypox infection during the current outbreak (3). The U.S. Department of Health and Human Services (HHS) allocated 1.1 million vials of JYNNEOS vaccine from the Strategic National Stockpile, with doses allocated to jurisdictions based on case counts and estimated size of population at risk (4). However, initial vaccine supplies were severely constrained relative to vaccine demand during the expanding outbreak. Some jurisdictions with highest incidence responded by prioritizing first dose administration during May-July (5,6). The FDA emergency use authorization (EUA) of 0.1 mL dosing for intradermal administration of JYNNEOS for persons aged ≥18 years on August 9, 2022, substantially expanded available vaccine supply
- Published
- 2022
- Full Text
- View/download PDF
3. TNF-R1 and FADD mediate UVB-Induced activation of K+ channels in corneal epithelial cells
- Author
-
L. Haarsma, John L. Ubels, Peter M. Boersma, and Mark P. Schotanus
- Subjects
0301 basic medicine ,Patch-Clamp Techniques ,Potassium Channels ,Cytochrome ,Ultraviolet Rays ,Fas-Associated Death Domain Protein ,Apoptosis ,Enzyme-Linked Immunosorbent Assay ,Article ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,0302 clinical medicine ,In Situ Nick-End Labeling ,Humans ,fas Receptor ,FADD ,Cells, Cultured ,integumentary system ,biology ,Cytochrome c ,Epithelium, Corneal ,Chromatography, Ion Exchange ,Sensory Systems ,Potassium channel ,Cell biology ,Ophthalmology ,Cytosol ,030104 developmental biology ,Receptors, Tumor Necrosis Factor, Type I ,Potassium ,030221 ophthalmology & optometry ,biology.protein ,Cytochromes ,RNA ,Signal transduction ,Intracellular ,Signal Transduction - Abstract
The goal of this study was to elucidate the role of Fas, TNF-R1, FADD and cytochrome c in UVB-induced K+ channel activation, an early step in UVB-induced apoptosis, in human corneal limbal epithelial (HCLE) cells. HCLE cells were treated with Fas, TNF-R1 or FADD siRNA and exposed to 80 or 150 mJ/cm2 UVB. K+ channel activation and loss of intracellular K+ were measured using whole-cell patch-clamp recording and ion chromatography, respectively. Cytochrome c was measured with an ELISA kit. Cells in which Fas was knocked down exhibited identical UVB-induced K+ channel activation and loss of intracellular K+ to control cells. Cells in which TNF-R1 or FADD were knocked down demonstrated reduced K+ channel activation and decreased loss of intracellular K+ following UVB, relative to control cells. Application of TNF-α, the natural ligand of TNF-R1, to HCLE cells induced K+ channel activation and loss of intracellular K+. Cytochrome c was translocated to the cytosol by 2 h after exposure to 150 mJ/cm2 UVB. However, there was no release by 10 min post-UVB. The data suggest that UVB activates TNF-R1, which in turn may activate K+ channels via FADD. This conclusion is supported by the observation that TNF-α also causes loss of intracellular K+. This signaling pathway appears to be integral to UVB-induced K+ efflux, since knockdown of TNF-R1 or FADD inhibits the UVB-induced K+ efflux. The lack of rapid cytochrome c translocation indicates cytochrome c does not play a role in UVB-induced K+ channel activation.
- Published
- 2017
- Full Text
- View/download PDF
4. Apoptosis of Corneal Epithelial Cells Caused by Ultraviolet B-induced Loss of K+ is Inhibited by Ba2+
- Author
-
L. Haarsma, John L. Ubels, Courtney D. Glupker, Peter M. Boersma, and Mark P. Schotanus
- Subjects
0301 basic medicine ,Ultraviolet Rays ,Apoptosis ,Article ,Cornea ,03 medical and health sciences ,In Situ Nick-End Labeling ,Extracellular ,medicine ,Humans ,Incubation ,Caspase ,Corneal epithelium ,TUNEL assay ,integumentary system ,biology ,Epithelial Cells ,Anatomy ,Molecular biology ,Ophthalmology ,030104 developmental biology ,medicine.anatomical_structure ,Caspases ,biology.protein ,DNA fragmentation ,Intracellular - Abstract
UVB exposure at ambient outdoor levels triggers rapid K(+) loss and apoptosis in human corneal limbal epithelial (HCLE) cells cultured in medium containing 5.5 mM K(+), but considerably less apoptosis occurs when the medium contains the high K(+) concentration that is present in tears (25 mM). Since Ba(2+) blocks several K(+) channels, we tested whether Ba(2+)-sensitive K(+) channels are responsible for some or all of the UVB-activated K(+) loss and subsequent activation of the caspase cascade and apoptosis. Corneal epithelial cells in culture were exposed to UVB at 80 or 150 mJ/cm(2). Patch-clamp recording was used to measure UVB-induced K(+) currents. Caspase-activity and TUNEL assays were performed on HCLE cells exposed to UVB followed by incubation in the presence or absence of Ba(2+). K(+) currents were activated in HCLE cells following UVB-exposure. These currents were reversibly blocked by 5 mM Ba(2+). When HCLE cells were incubated with 5 mM Ba(2+) after exposure to UVB, activation of caspases-9, -8, and -3 and DNA fragmentation were significantly decreased. The data confirm that UVB-induced K(+) current activation and loss of intracellular K(+) leads to activation of the caspase cascade and apoptosis. Extracellular Ba(2+) inhibits UVB-induced apoptosis by preventing loss of intracellular K(+) when K(+) channels are activated. Ba(2+) therefore has effects similar to elevated extracellular K(+) in protecting HCLE cells from UVB-induced apoptosis. This supports our overall hypothesis that elevated K(+) in tears contributes to protection of the corneal epithelium from adverse effects of ambient outdoor UVB.
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.